Repatha (evolocumad) (inyectable para colesterol). No "salva" vidas, mismos muertos. < 1,5% infartos a 2 mill $. Repatha (evolocumad) does not "save lives", same deaths. Prevents 1.5% of major cardiac events, at 2 mill $ cost. http://www.healthnewsreview.org/…/no-surprise-repatha-real…/
